NO176043C - Fremgangsmåte til fremstilling av en kolestyramintablett - Google Patents

Fremgangsmåte til fremstilling av en kolestyramintablett

Info

Publication number
NO176043C
NO176043C NO901183A NO901183A NO176043C NO 176043 C NO176043 C NO 176043C NO 901183 A NO901183 A NO 901183A NO 901183 A NO901183 A NO 901183A NO 176043 C NO176043 C NO 176043C
Authority
NO
Norway
Prior art keywords
preparation
cholestyramine
tablet
cholestyramine tablet
Prior art date
Application number
NO901183A
Other languages
English (en)
Norwegian (no)
Other versions
NO901183L (no
NO176043B (no
NO901183D0 (no
Inventor
Robert J Bequette
Bruce A Bonenberger
Claude E Gallian
John R Reckelhoff
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO901183D0 publication Critical patent/NO901183D0/no
Publication of NO901183L publication Critical patent/NO901183L/no
Publication of NO176043B publication Critical patent/NO176043B/no
Publication of NO176043C publication Critical patent/NO176043C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO901183A 1989-03-16 1990-03-14 Fremgangsmåte til fremstilling av en kolestyramintablett NO176043C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/324,167 US4956182A (en) 1989-03-16 1989-03-16 Direct compression cholestyramine tablet and solvent-free coating therefor

Publications (4)

Publication Number Publication Date
NO901183D0 NO901183D0 (no) 1990-03-14
NO901183L NO901183L (no) 1990-09-17
NO176043B NO176043B (no) 1994-10-17
NO176043C true NO176043C (no) 1995-01-25

Family

ID=23262387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901183A NO176043C (no) 1989-03-16 1990-03-14 Fremgangsmåte til fremstilling av en kolestyramintablett

Country Status (34)

Country Link
US (1) US4956182A (de)
EP (1) EP0387885B1 (de)
JP (1) JP2974719B2 (de)
KR (1) KR0140211B1 (de)
CN (1) CN1047935C (de)
AR (1) AR246012A1 (de)
AT (1) ATE128031T1 (de)
AU (1) AU617601B2 (de)
BG (1) BG60501B1 (de)
CA (1) CA2012300A1 (de)
CS (1) CS277488B6 (de)
CY (1) CY1899A (de)
DD (1) DD292837A5 (de)
DE (1) DE69022452T2 (de)
DK (1) DK0387885T3 (de)
EG (1) EG19669A (de)
ES (1) ES2078917T3 (de)
FI (1) FI92464C (de)
GR (1) GR3017460T3 (de)
HK (1) HK51396A (de)
HU (1) HU209958B (de)
IE (1) IE70591B1 (de)
IL (1) IL93720A0 (de)
MY (1) MY109744A (de)
NO (1) NO176043C (de)
NZ (1) NZ232864A (de)
OA (1) OA09198A (de)
PL (1) PL163301B1 (de)
PT (1) PT93452B (de)
RO (1) RO106953B1 (de)
RU (1) RU2069558C1 (de)
YU (1) YU52390A (de)
ZA (1) ZA902001B (de)
ZW (1) ZW1890A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US5262167A (en) * 1990-12-20 1993-11-16 Basf Corporation Edible, non-baked low moisture cholestyramine composition
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
MX9702162A (es) * 1994-09-22 1997-06-28 Akzo Nobel Nv Procedimiento para hacer unidades de dosis mediante granulacion en humedo.
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
MXPA01004381A (es) 1998-11-02 2005-09-08 Elan Corp Plc Composicion de multiparticulado de liberacion modificada.
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR100889069B1 (ko) 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
AU2738302A (en) 2000-10-30 2002-05-15 Euro Celtique Sa Controlled release hydrocodone formulations
JP2004518709A (ja) * 2001-02-13 2004-06-24 アストラゼネカ・アクチエボラーグ 新規放出修飾製剤
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
NZ532096A (en) 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
RU2234915C2 (ru) * 2002-06-04 2004-08-27 Дж. Б. Кемикалс энд Фармасьютикалс Лтд. Твердая фармацевтическая композиция для перорального введения и способ ее получения
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
WO2005115352A1 (de) * 2004-05-24 2005-12-08 Mepha Ag Trockenbeschichtungsverfahren
ES2317313T3 (es) * 2004-10-19 2009-04-16 Krka, Tovarna Zdravil, D.D., Novo Mesto Composicion farmaceutica solida que comprende clorhidrato de donepezilo.
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
EP2050456A4 (de) * 2006-08-09 2013-01-23 Mitsubishi Tanabe Pharma Corp Tablette
EP2066293A2 (de) 2006-09-29 2009-06-10 Genzyme Corporation Amid-dendrimer-zusammensetzungen
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
US9993422B2 (en) 2012-04-18 2018-06-12 SpecGx LLC Immediate release, abuse deterrent pharmaceutical compositions
CN105848894B (zh) 2013-10-25 2018-01-23 株式会社可乐丽 多层薄膜和包含其的夹层玻璃用中间膜
WO2016004170A1 (en) * 2014-07-03 2016-01-07 Mallinckrodt Llc Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
ES2874669T3 (es) * 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
CN108601739B (zh) * 2016-02-09 2022-01-04 阿尔比里奥公司 考来烯胺丸剂及其制备方法
EP3856160A4 (de) 2018-09-25 2022-07-06 SpecGx LLC Missbrauchssichere kapseldarreichungsformen mit sofortiger freisetzung
CN114053234A (zh) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 一种阿卡波糖片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
US4956182A (en) 1990-09-11
NZ232864A (en) 1992-04-28
YU52390A (en) 1991-10-31
KR900013946A (ko) 1990-10-22
FI901241A0 (fi) 1990-03-13
AU5136790A (en) 1990-09-20
PL163301B1 (en) 1994-03-31
DE69022452D1 (de) 1995-10-26
JP2974719B2 (ja) 1999-11-10
HK51396A (en) 1996-03-29
CA2012300A1 (en) 1990-09-16
CS277488B6 (en) 1993-03-17
MY109744A (en) 1997-05-31
PT93452B (pt) 1996-12-31
NO901183L (no) 1990-09-17
ATE128031T1 (de) 1995-10-15
FI92464B (fi) 1994-08-15
AU617601B2 (en) 1991-11-28
PT93452A (pt) 1990-11-07
AR246012A1 (es) 1994-03-30
NO176043B (no) 1994-10-17
BG91463A (bg) 1993-12-24
GR3017460T3 (en) 1995-12-31
CN1045921A (zh) 1990-10-10
KR0140211B1 (ko) 1998-06-01
HU209958B (en) 1994-12-28
RU2069558C1 (ru) 1996-11-27
IE70591B1 (en) 1996-12-11
EP0387885A2 (de) 1990-09-19
NO901183D0 (no) 1990-03-14
DK0387885T3 (da) 1995-11-06
FI92464C (fi) 1994-11-25
OA09198A (fr) 1992-06-30
RO106953B1 (ro) 1993-08-30
EP0387885A3 (de) 1992-06-17
IL93720A0 (en) 1990-12-23
IE900941L (en) 1990-09-16
EP0387885B1 (de) 1995-09-20
HU901429D0 (en) 1990-06-28
JPH03236326A (ja) 1991-10-22
DD292837A5 (de) 1991-08-14
CN1047935C (zh) 2000-01-05
DE69022452T2 (de) 1996-03-14
ES2078917T3 (es) 1996-01-01
ZA902001B (en) 1990-11-28
EG19669A (en) 1995-08-30
HUT54489A (en) 1991-03-28
BG60501B1 (bg) 1995-06-30
ZW1890A1 (en) 1990-10-31
CY1899A (en) 1990-03-15

Similar Documents

Publication Publication Date Title
NO176043C (no) Fremgangsmåte til fremstilling av en kolestyramintablett
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
NO904513D0 (no) Fremgangsmaate for fremstilling av et naeringsmiddel.
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
NO171792C (no) Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer
FI890186A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
FI890185A7 (fi) Menetelmä 1-alkyyli-5-nitroimidatsolien valmistamiseksi
NO173280C (no) Fremgangsm}te for fremstilling av colestipolhydroklorid
GB8916682D0 (en) Pharmaceutical compounds
FI890188A7 (fi) Menetelmä 1-hydroksialkyyli-2-metyyli-5-nitroimidatsolien valmistamiseksi
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
FI902590A7 (fi) Menetelmä 2-oksoindoli-1-karboksamidien valmistamiseksi
NO904643D0 (no) Fremgangsmaate til fremstilling av en for sproeytestoeping egnet vinylklorid/butylakrylat-podekopolymer.
NO905000D0 (no) Fremgangsmaate for fremstilling av et polymersystem for vanneroderbare belegg.
FI93363C (fi) Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi
GB2198732B (en) Process for the manufacture of photopolymerisable materials
FI904950A7 (fi) Menetelmä 3-alkoksi-4-hydroksibentsaldehydien valmistamiseksi
NO963876L (no) Fremgangsmåte for fremstilling av polypeptider
NO942454L (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
NO174554C (no) Fremgangsmåte til fremstilling av 1,2:3,5-di-O-iso-propyliden-
NO960829D0 (no) Fremgangsmåte for fresmtilling av 13-alkyl-11 r
NO940861L (no) Fremgangsmåte for fremstilling av substituerte 2-aminoteraliner
CA64087S (en) Tablet
CA63452S (en) Tablet

Legal Events

Date Code Title Description
MK1K Patent expired